$4.13
0.051.23%
At Close: -
$4.10
-0.03-0.73%
After Hours: 4:23 PM EDT
15 minutes delayed
Arbutus Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.11 | $-0.10 | -10.0 % |
Mar 2024 | 2024-05-02 | $-0.10 | $-0.11 | 9.09 % |
Dec 2023 | 2024-02-29 | $-0.12 | $-0.12 | 0.00 % |
Sep 2023 | 2023-11-07 | $-0.12 | $-0.11 | -9.09 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $1.73M | $1.75M | -1.37 % |
Mar 2024 | 2024-05-02 | $1.53M | $2.15M | -28.7 % |
Dec 2023 | 2024-02-29 | $2.15M | $4.79M | -55.2 % |
Sep 2023 | 2023-11-07 | $4.66M | $4.75M | -1.94 % |
Arbutus Biopharma (ABUS) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.11, which missed the estimate of $-0.10.
The Actual Revenue was $1.7M, which missed the estimate of $1.8M.
Browse earnings estimates, EPS, and revenue on all stocks.